Cargando…
Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model
Fibromyalgia (FM) is a chronic, widespread pain disorder generally of a non-inflammatory nature with many known affective and cognitive comorbidities. There is promise in the implementation of hyperbaric oxygen therapy (HBO(2)) for alleviating FM pain and comorbidities, despite no work investigating...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014544/ https://www.ncbi.nlm.nih.gov/pubmed/36937563 http://dx.doi.org/10.3389/fpain.2023.1097457 |
_version_ | 1784907015364018176 |
---|---|
author | Argenbright, Cassie M. Bland, Michelle K. Michener, Sydney L. Wilson, Judy R. Fuchs, Perry N. |
author_facet | Argenbright, Cassie M. Bland, Michelle K. Michener, Sydney L. Wilson, Judy R. Fuchs, Perry N. |
author_sort | Argenbright, Cassie M. |
collection | PubMed |
description | Fibromyalgia (FM) is a chronic, widespread pain disorder generally of a non-inflammatory nature with many known affective and cognitive comorbidities. There is promise in the implementation of hyperbaric oxygen therapy (HBO(2)) for alleviating FM pain and comorbidities, despite no work investigating the efficacy of this treatment in prominent preclinical FM models. This project aimed to investigate the affective components, specifically anhedonia and anxiety, associated with an acidic saline model of FM in rats. We investigated the acidic saline model's ability to produce the sensory component of FM through reduced mechanical thresholds, as well as anxiety-like and avoidance behaviors through measures of open field and place escape/avoidance. We further investigated the use of pregabalin, a known FM therapeutic agent, in reducing negative sensory and affective measures within the model. Results revealed insignificant between-group differences for measures of anxiety, despite animals in the FM condition showing significantly reduced mechanical thresholds. Results further revealed that the acidic saline model was effective in increasing place escape/avoidance behavior among animals in the FM condition, with pregabalin reducing avoidance behaviors. In addition, we investigated the role of HBO(2) [two 60-minute treatments at 2.0 ATA (atmospheres absolute)] in alleviating FM-like pain, anxiety, and anhedonia in the acidic saline model, utilizing mechanical paw withdrawal thresholds, open field, and sucrose preference measures. Results revealed that the acidic saline model produced reduced thresholds indicative of FM-like pain. Data did not provide support for the presence of anxio-depressive comorbidities associated with the FM model. HBO(2) treatment did not significantly increase mechanical thresholds as expected. Future studies should seek to investigate the experimental circumstances within which the acidic saline model produces negative affect alongside hyperalgesia in order to contribute to the development of a multidimensional FM treatment methodology. |
format | Online Article Text |
id | pubmed-10014544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100145442023-03-16 Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model Argenbright, Cassie M. Bland, Michelle K. Michener, Sydney L. Wilson, Judy R. Fuchs, Perry N. Front Pain Res (Lausanne) Pain Research Fibromyalgia (FM) is a chronic, widespread pain disorder generally of a non-inflammatory nature with many known affective and cognitive comorbidities. There is promise in the implementation of hyperbaric oxygen therapy (HBO(2)) for alleviating FM pain and comorbidities, despite no work investigating the efficacy of this treatment in prominent preclinical FM models. This project aimed to investigate the affective components, specifically anhedonia and anxiety, associated with an acidic saline model of FM in rats. We investigated the acidic saline model's ability to produce the sensory component of FM through reduced mechanical thresholds, as well as anxiety-like and avoidance behaviors through measures of open field and place escape/avoidance. We further investigated the use of pregabalin, a known FM therapeutic agent, in reducing negative sensory and affective measures within the model. Results revealed insignificant between-group differences for measures of anxiety, despite animals in the FM condition showing significantly reduced mechanical thresholds. Results further revealed that the acidic saline model was effective in increasing place escape/avoidance behavior among animals in the FM condition, with pregabalin reducing avoidance behaviors. In addition, we investigated the role of HBO(2) [two 60-minute treatments at 2.0 ATA (atmospheres absolute)] in alleviating FM-like pain, anxiety, and anhedonia in the acidic saline model, utilizing mechanical paw withdrawal thresholds, open field, and sucrose preference measures. Results revealed that the acidic saline model produced reduced thresholds indicative of FM-like pain. Data did not provide support for the presence of anxio-depressive comorbidities associated with the FM model. HBO(2) treatment did not significantly increase mechanical thresholds as expected. Future studies should seek to investigate the experimental circumstances within which the acidic saline model produces negative affect alongside hyperalgesia in order to contribute to the development of a multidimensional FM treatment methodology. Frontiers Media S.A. 2023-03-01 /pmc/articles/PMC10014544/ /pubmed/36937563 http://dx.doi.org/10.3389/fpain.2023.1097457 Text en © 2023 Argenbright, Bland, Michener, Wilson and Fuchs. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pain Research Argenbright, Cassie M. Bland, Michelle K. Michener, Sydney L. Wilson, Judy R. Fuchs, Perry N. Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
title | Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
title_full | Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
title_fullStr | Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
title_full_unstemmed | Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
title_short | Pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
title_sort | pregabalin and hyperbaric oxygen therapy on pain thresholds and anxio-depressive behaviors in a preclinical fibromyalgia pain model |
topic | Pain Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014544/ https://www.ncbi.nlm.nih.gov/pubmed/36937563 http://dx.doi.org/10.3389/fpain.2023.1097457 |
work_keys_str_mv | AT argenbrightcassiem pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel AT blandmichellek pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel AT michenersydneyl pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel AT wilsonjudyr pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel AT fuchsperryn pregabalinandhyperbaricoxygentherapyonpainthresholdsandanxiodepressivebehaviorsinapreclinicalfibromyalgiapainmodel |